|
|
News Breaks | | | | December 19, 2012 | | 13:24 EDT |  | MCK, GSK, CAH, ABC | GlaxoSmithKline settles nasal spray litigation for $150M, Reuters reports
GlaxoSmithKline Plc (GSK) has reached a preliminary $150M settlement with U.S. drug wholesalers regarding generic nasal spray litigation, according to Reuters. Reference Link | |
|
News For GSK;ABC;CAH;MCK From The Last 14 Days Check below for free stories on GSK;ABC;CAH;MCK the last two weeks. |
|
|
| May 17, 2013 | | 12:33 EDT |  | ABC | AmerisourceBergen receives approval of Walgreens, Alliance Boots investment
AmerisourceBergen (ABC) announced that the parties have received regulatory approval of the previously disclosed agreement for Walgreen (WAG) and Alliance Boots GmbH to purchase an equity stake in the company. AmerisourceBergen continues to expect the new agreements to contribute an incremental $25B in revenues and approximately 20c in earnings per share in FY14, excluding the amortization of certain expenses related to the transaction and the warrants issued, certain non-recurring costs and a potential LIFO charge, and net of certain start up expenses. In addition, the company reiterated its expectations for financial performance for fiscal year 2013, which includes expected revenue growth in the 11%-13% range, and diluted earnings per share from continuing operations in the lower half of the range of $3.04 to $3.14, excluding certain expenses related to the relationship with Walgreens and Alliance Boots and the warrants issued, and the expected LIFO charge from onboarding of additional branded inventory. | | | May 15, 2013 | | 14:56 EDT |  | MCK | McKesson has a conference call hosted by JPMorgan
 Subscribe for More Information | | | May 14, 2013 | | 07:24 EDT | | GSK | EBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16. | | | 07:18 EDT | | ABC, CAH | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. | | | May 13, 2013 | | 16:25 EDT |  | GSK | On The Fly: Closing Wrap
Stocks on Wall Street were little changed from their opening levels as investors weighed the potential end of the Fed's quantitative easing program against a better than expected report on retail sales. The Wall Street Journal's Jon Hilsenrath suggested in a report over the weekend that the Federal Reserve has mapped a QE exit strategy. The report paired with the retail sales data left the market lacking conviction in either direction today, as the averages spent the majority of the session range-bound near the flatline. ECONOMIC EVENTS: In the U.S., retail sales rose 0.1% in April, which beat expectations for a 0.3% decline. Retail sales excluding autos, gas, and building materials rose 0.6%, which was also better than expected. Business inventories were flat in March, versus expectations for a 0.3% gain. In Asia, Chinese factory output grew 9.3% annually in April, which was up from 8.9% in March but still missed expectations for a 9.5% growth rate. COMPANY NEWS: The Supreme Court ruled unanimously that Monsanto's (MON) patented genetically altered soybeans are protected and that farmers cannot use them to create new seeds without paying the company... Dell's (DELL) special committee publicly asked for more information from Carl Icahn and Southeastern Asset Management about their proposed leveraged recapitalization. This request follows television interviews by Icahn last Friday in which he discussed his Dell proposal, as well as a weekend report in Barron's saying the Icahn and Southeastern plan could be a better deal for shareholders. MAJOR MOVERS: Among the notable gainers was Theravance (THRX), up $6.26, or 17.92%, to $41.20 after Elan Corporation (ELN) bought a stake in the potential future royalty payments from four respiratory programs partnered with GlaxoSmithKline (GSK) in exchange for $1B in cash. Also higher was Tesla (TSLA), which rose $11.04, or 14.38%, to $87.80 in its third straight double-digit percentage gain following a better-than-expected earnings report last week. Among the noteworthy losers was Barnes & Noble (BKS), down $2.21, or 9.48%, to $21.10 after the blog InsiderMonkey disputed a previous report about Microsoft's (MSFT) interest in the bookseller's NOOK assets. Also lower was JoS. A. Bank (JOSB), down $3.31, or 7.16%, to $42.90 after the company's first quarter earnings view came in below expectations. INDICES: The Dow was down 26.81, or 0.18%, to 15,091.68; the Nasdaq was up 2.21, or 0.06%, to 3,438.79; and the S&P 500 was nearly unchanged at 1,633.77. | | | 12:20 EDT | | GSK | On The Fly: Midday Wrap
Subscribe for More Information | | | 08:05 EDT | | ABC | Frazier Healthcare acquires AnderesonBrecon from AmerisourceBergen
Subscribe for More Information | | | 07:32 EDT | | ABC | AmerisourceBergen says divestiture of AndersonBrecon has no impact on guidance
Subscribe for More Information | | | 06:42 EDT | | CAH | Cardinal Health management to meet with ISI Group
Meetings to be held May 13-14 hosted by ISI Group. | | | 05:44 EDT | | GSK | Elan provides additional information on Elan/Theravance agreement
Subscribe for More Information | | | | 05:35 EDT | | GSK | Theravance, Elan enter into $1B royalty participation agreement
Subscribe for More Information | | | May 10, 2013 | | 12:42 EDT | | GSK | GlaxoSmithKline, Theravance confirm FDA approval of Breo Ellipta
Subscribe for More Information | | | 11:48 EDT | | GSK | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information | | | 11:15 EDT | | GSK | FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease
Subscribe for More Information | | | 06:53 EDT | | GSK | GlaxoSmithKline, Merck to discount cancer vaccine in poor nations, NY Times says
Subscribe for More Information | | | May 9, 2013 | | 08:51 EDT | | MCK | Humana appoints Roy A. Beveridge, M.D., as Chief Medical Officer
Humana (HUM) has appointed Roy A. Beveridge, M.D. as Senior VP and Chief Medical Officer, effective June 17. Dr. Beveridge is currently Chief Medical Officer for McKesson Specialty Health, a subsidiary of McKesson (MCK). | | | May 7, 2013 | | 16:27 EDT |  | MCK | McKesson sees FY14 adjusted EPS $7.90-$8.20, consensus $8.06
Subscribe for More Information | | | 16:25 EDT | | MCK | McKesson reports Q4 adjusted EPS with items $1.45, consensus $2.30
Subscribe for More Information | | | 15:34 EDT | | MCK | Notable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include The Walt Disney Company (DIS), consensus 76c; Mondelez International (MDLZ), consensus 34c; Williams Companies (WMB), consensus 24c; McKesson (MCK), consensus $2.30; Marathon Oil (MRO), consensus 72c; Williams Partners (WPZ), consensus 50c; Symantec (SYMC), consensus 38c; Whole Foods Market(WFM), consensus 73c; CA Technologies (CA), consensus 55c; TripAdvisor (TRIP), consensus 46c; Electronic Arts (EA), consensus 58c. | | | 07:24 EDT | | CAH | Mizuho Securities to host a conference
Subscribe for More Information | | |
|
|
|
|
|
|
